There are only a few studies describing the etiologic spectrum of biopsy-proven peripheral neuropathies in children. This study reviewed the clinical, electrophysiological, and pathologic profile of 239 children (≤18 years of age) who have undergone nerve biopsy in a tertiary care centre for neurologic disorders and analyzed the etiologic spectrum and utility of nerve biopsy. The clinical profile, neuropathologic findings, and other investigations were combined to infer the final diagnosis. Neuropathy was detected in 199 biopsies; axonal pathology in 43%; demyelination in 41%; mixed pattern in 8%; and nonspecific findings in 8%. The major diagnostic categories included hereditary neuropathies (48%), heredodegenerative and metabolic disorders (27%), and inflammatory neuropathies (12%). Nerve biopsy proved most helpful in diagnosis of demyelinating and inflammatory neuropathies, reiterating its usefulness in specific situations.
OuvrierRAWilmshurstJM. Overview of the neuropathies. In: JonesHRJrDe VivoDCDarrasBT, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician’s Approach. Philadelphia, PA: Butterworth-Heinemann; 2003:339–359.
2.
WilmshurstJMOuvrierR. Hereditary peripheral neuropathies of childhood: an overview for clinicians. Neuromuscul Disord. 2011;21:763–775.
3.
HagbergBLyonG. Pooled European series of hereditary peripheral neuropathies in infancy and childhood. A “correspondence workshop” report of the European Federation of Child Neurology Societies (EFCNS). Neuropediatrics. 1981;12:9–17.
4.
HagbergBWesterbergB. The nosology of genetic peripheral neuropathies in Swedish children. Dev Med Child Neurol. 1983;25:3–18.
5.
McleodJGPollardJDMacaskillP. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. 1999;46:910–913.
6.
WilmshurstJM. Diagnosis and management of pediatric peripheral neuropathies in resource-poor settings. Future Neurol. 2013;8:133–148.
7.
KoulRChackoAJavedH. A profile of childhood neuropathies at a university hospital in Oman. Saudi Med J. 2002;23:450–456.
8.
PolatMTekgulHKilincerA. Electrodiagnostic pattern approach for childhood polyneuropathies. Pediatr Neurol. 2006;35:11–17.
9.
ShaboGPasmanJWvan AlfenNWillemsenMA. The spectrum of polyneuropathies in childhood detected with electromyography. Pediatr Neurol. 2007;36:393–396.
10.
OuvrierRAMcLeodJG. Chronic peripheral neuropathy in childhood: an overview. Aust Paediatr J. 1988;24
(suppl 1):80–82.
11.
WilmshurstJMPollardJDNicholsonG. Peripheral neuropathies of infancy. Dev Med Child Neurol. 2003;45:408–414.
12.
KararizouEKarandreasNDavakiP. Polyneuropathies in teenagers: a clinicopathological study of 45 cases. Neuromuscul Disord. 2006;16:304–307.
VranckenAFKalmijnSBuskensE. Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study. J Neurol Neurosurg Psychiatry. 2006;77:397–401.
15.
HiltonDAJacobJHousehamLTengahC. Complications following sural and peroneal nerve biopsies. J Neurol Neurosurg Psychiatry. 2007;78:1271–1272.
16.
SommerCBrandnerSDyckPJ. 147th ENMC international workshop: guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands. Neuromuscul Disord. 2008;18:90–96.
17.
YiuEMRyanMM. Demyelinating prenatal and infantile developmental neuropathies. J Peripher Nerv Syst. 2012;17:32–52.
18.
MidroniGBilbaoJM. Peripheral neuropathy and the role of nerve biopsy. In: MidroniGBilbaoJMCohenSM, eds. Biopsy Diagnosis of Peripheral Neuropathy. Boston: Butterworth-Heinemann; 1995:1–13.
19.
ChiaLFernandezALacroixC. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly: a retrospective review of 100 consecutive patients. Brain. 1996;119:1091–1098.
20.
GabrielCMHowardRKinsellaN. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry. 2000;69:442–446.
21.
NeundorferBGrahmannFEngelhardtAHarteU. Postoperative effects and value of sural nerve biopsies: a retrospective study. Eur Neurol. 1990;30:350–352.
22.
ArgovZSteinerISofferD. The yield of sural nerve biopsy in the evaluation of peripheral neuropathies. Acta Neurol Scand. 1989;79:243–245.
23.
OhSJ. Diagnostic usefulness and limitations of the sural nerve biopsy. Yonsei Med J. 1990;31:1–26.
24.
ParanoEUnciniADe VivoDCLovelaceRE. Electrophysiologic correlates of peripheral nervous system maturation in infancy and childhood. J Child Neurol. 1993;8:336–338.
25.
EnglandJDGronsethGSFranklinG. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:185–192.
26.
VerhoevenKClaeysKGZüchnerS. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain. 2006;129:2093–2102.
27.
BomontPCavalierLBlondeauF. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet. 2000;26:370–374.
28.
SimmonsZWaldJAlbersJW. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve. 1997;20:1008–1015.
29.
Lancet Neurology. Leprosy as a neurological disease. Lancet Neurol. 2009;8:217.
30.
KhanAKoranneRVBajajPRaviB. Clinico-histopathological correlation of skin and nerve in leprosy. J Dermatol. 2004;31:632–636.
31.
HarelLMukamelMBrikR. Peripheral neuropathy in pediatric lupus erythematosus. Pediatr Neurol. 2002;27:53–56.
32.
GinsbergLMalikOKentonRA. Coexistent hereditary and inflammatory neuropathy. Brain. 2004;127:193–202.
